Abstract
Evaluating anti-oxidant potential of Ganoderic acid A in STAT 3 pathway in Prostate cancer. Molecular docking and ADMET activities of different isoforms of ganoderic acid on STAT 3 pathway were performed by Maestro 9.6 (Schrödinger Inc). The ganoderic acid A is best-docked among isoforms which analyses the expression level of antioxidant and STAT 3 pathway in PC-3 cells. The receptor-based molecular docking reveals the best binding interaction of SH2 domain of STAT3 and ganoderic acid A with GScore (−6.134), kcal/mol, Lipophilic EvdW (−1.83), Electro (−1.1), Glide emodel (−31.857), H bond (1.98), MM-GBSA (−69.555). The molecular docking QikProp analyzed the absorption, distribution, metabolism, excretion, and toxicity (ADME/T). The ganoderic acid A is best-docked among isoforms which downregulates the expression of STAT 3 in PC-3 cells. Moreover, ganoderic acid A inhibits proliferation, viability, ROS, DPPH, and analyzed the expression of SOD1, SOD2, and SOD3 by Real time PCR in a PC-3 cell in a dose-dependent manner. Molecular docking revealed the mechanistic binding of Ganoderic acid A in STAT3 signaling, which inhibits the proliferation, viability, and ROS in PC-3 cells.
Similar content being viewed by others
References
Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S, Sung B (2009) Signal transducer and activator of transcription-3, inflammation, and cancer. Ann N Y Acad Sci 1171:59–76
Rawlings JS, Rosler KM, Harrison DA (2004) The JAK/STAT signaling pathway. J Cell Sci 117:1281–1283
Dave B, Landis M D, Tweardy D, Chang J, Dobrolecki L, Wu M, Zhang X, Westbrook T, Hilsenbeck S, Liu D (2012) Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model. PloS One 7:e30207
Yu H, Kortylewski M, Pardoll D (2007) Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 7:41–51
Negi A, Gill B (2013) Success stories of enolate form of drugs. PharmaTutor 1:45–53
Yao X, Li G, Xu H, Lü C (2012) Inhibition of the JAK-STAT3 signaling pathway by ganoderic acid A enhances chemosensitivity of HepG2 cells to cisplatin. Planta Med 78:1740–1748
Atreya R, Neurath M (2008) Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Curr Drug Targets 9:369–374
Negi A, Navgeet, Gill BS, Anand SS (2014) Tilling: Versatile reverse genetic tool. PharmaTutor 2:26–32
Buettner R, Mora LB, Jove R (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8:945–954
Anand SS, Gill BS (2015) Breakthroughs in Epigenetics. PharmaTutor 3:16–24
Glienke W, Maute L, Wicht J, Bergmann L (2009) Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression. Cancer Invest 28:166–171
Cao H-H, Tse AK-W, Kwan H-Y, Yu H, Cheng C-Y, Su T, Fong W-F, Yu Z-L (2014) Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem Pharmacol 87:424–434
Lee J, Hahm E-R, Singh SV (2010) Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. Carcinogenesis 31:1991–1998
Pandey MK, Sung B, Aggarwal BB (2010) Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP-1 in human multiple myeloma cells. Int J Cancer 127:282–292
Pathak AK, Bhutani M, Nair AS, Ahn KS, Chakraborty A, Kadara H, Guha S, Sethi G, Aggarwal BB (2007) Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells. Mol Cancer Res 5:943–955
Gill BS, Sharma P, Kumar R, Kumar S (2015) Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling. Tumor Biol 37:2789–2804
Gill B, Alex J, Kumar S (2016) Missing link between microRNA and prostate cancer. Tumour Biol 37:5683–5704
Gill BS, Kumar S, Navgeet (2016) Triterpenes in cancer: significance and their influence. Mol Biol Rep. doi:10.1007/s11033-016-4032-9
Gill B S, Kumar S (2015) Differential algorithms-assisted molecular modeling-based identification of mechanistic binding of ganoderic acids. Med Chem Res 24:3483–3493
Becker S, Groner B, Muller CW (1998) Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 394:145–151
Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118:11225–11236
Shivakumar D, Williams J, Wu Y, Damm W, Shelley J, Sherman W (2010) Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field. J Chem Theory Comput 6:1509–1519
Singh P, Bast F (2015) Screening and biological evaluation of myricetin as a multiple target inhibitor insulin, epidermal growth factor, and androgen receptor; in silico and in vitro. Invest New Drugs 33:575–593
Repasky MP, Shelley M, Friesner RA (2007) Flexible ligand docking with Glide. Curr Protoc Bioinformatics: 8–12
Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749
Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein–ligand complexes. J Med Chem 49:6177–6196
Sitkoff D, Sharp KA, Honig B (1994) Accurate calculation of hydration free energies using macroscopic solvent models. J Phy Chem 98:1978–1988
Lyne PD, Lamb ML, Saeh JC (2006) Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J Med Chem 49:4805–4808
Jorgensen WL, Duffy EM (2002) Prediction of drug solubility from structure. Adv Drug Deliv Rev 54:355–366
Aguirre-Moreno A, Campos-Pena V, del Rio-Portilla F, Herrera-Ruiz M, Leon-Rivera I, Montiel E, Rodriguez V, Tello I, Villeda-Hernandez J (2013) Anticonvulsant and neuroprotective effects of oligosaccharides from lingzhi or reishi medicinal mushroom, ganoderma lucidum (Higher Basidiomycetes). Int J Med Mushrooms 15:555–568
Cheng P G, Phan C-W, Sabaratnam V, Abdullah N, Abdulla M A, Kuppusamy U R (2013) Polysaccharides-rich extract of ganoderma lucidum (MA Curtis: Fr.) P. Karst Accelerates wound healing in streptozotocin-induced diabetic rats. Evid Based Complement Alternat Med 2013:671252. doi:10.1155/2013/671252
Singh P, Bast F (2015) High-throughput virtual screening, identification and in vitro biological evaluation of novel inhibitors of signal transducer and activator of transcription 3. Med Chem Res 24:2694–2708
Acknowledgments
Authors thanks, Central University of Punjab, Bathinda, for providing the necessary facilities to carry out the present work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Gill, B.S., Kumar, S. & Navgeet Evaluating anti-oxidant potential of ganoderic acid A in STAT 3 pathway in prostate cancer. Mol Biol Rep 43, 1411–1422 (2016). https://doi.org/10.1007/s11033-016-4074-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-016-4074-z